TMCnet News
Printed Electronics for Healthcare, Cosmetics and Pharmaceuticals 2012-2022 Out Now(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (http://www.researchandmarkets.com/research/ddvfz5/printed) has announced the addition of the "Printed Electronics for Healthcare, Cosmetics and Pharmaceuticals 2012-2022" report to their offering. Printed electronics for healthcare and beauty encompasses stretchable, flexible, conformal and sometimes biodegradable electronics and electrics. It is very thin and lightweight, even in hybrid constructions that, for now, incorporate conventional integrated circuits (IC), light emitting diodes (LED) and other chips in a partly printed device in order to perform functions not yet possible with entirely printed surfaces. Saving up to 40% of cost, space and weight and making new things possible are typical achievements. This is the only up to date, comprehensive report on this rapidly emerging technology and covers; electronic medical implants, patches, disposables, and drug and cosmetic dispensing: stretchable, flexible, wide area, low cost, disposable electronics. Printed and potentially printed thin film electronics provides many benefits in healthcare and beauty including low cost in many cases, even to the point of disposability, and greatly enhanced functionality in other cases. Frequently, it makes new things possible. It does this in two ways. It is the basis of totally new components relying on new physical principles, examples including metamaterials and memristors. Secondly it makes possible the creation of new devices such as self-powered implants that never need a battery to be replaced. Battery replacement by surgical procedure causes up to 3% of fatalities. This new technology takes an increasing variety of forms from implants to smart skin patches, radio frequency identification (RFID) and smart packaging. The human interface is improved with sound, moving images, light emitting graphics and so on. Other functions achieved are as widely different as automatic drug delivery and anticounterfeiting. Multiple benefits are commonplace. In a drug trial, recording which pill was removed, when, and plotting this helps patients to do better - get well sooner - and reduces the amount of corrupt data. Who should buy this report Those funding, developing, selling or buying and using the new electronics and electrics in medical and beauty applications. Academics, legislators, consultants, analysts and other interested parties. For more information visit http://www.researchandmarkets.com/research/ddvfz5/printed CONTACT: Research and Markets, Laura Wood, Senior Manager. [email protected] Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Computing and Technology (http://www.researchandmarkets.com/categories.asp cat_id=4&campaign_id=ddvfz5), Consumer and Personal (http://www.researchandmarkets.com/categories.asp cat_id=5&campaign_id=ddvfz5), Healthcare and Medical Devices (http://www.researchandmarkets.com/categories.asp cat_id=12&campaign_id=ddvfz5), Pharmaceuticals (http://www.researchandmarkets.com/categories.asp cat_id=16&campaign_id=ddvfz5) ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). (c) 2013 M2 COMMUNICATIONS |